PharmGen Science Inc (004720) — Capital Reinvestment Ratio
PharmGen Science Inc (004720) has a Capital Reinvestment Ratio of 0.42x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩1.91 Billion) in capital expenditures (₩799.96 Million). See PharmGen Science Inc (004720) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
PharmGen Science Inc Capital Reinvestment Ratio (2011–2024)
This chart tracks PharmGen Science Inc's Capital Reinvestment Ratio across 10 annual periods. Check total reinvestment intensity of PharmGen Science Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for PharmGen Science Inc (2011–2024)
Year-by-year Capital Reinvestment Ratio for PharmGen Science Inc from 2011 to 2024. For live market cap and broader valuation context, see 004720 market cap.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.17x | ₩2.38 Billion | ₩2.78 Billion | ▲ +92.9% |
| 2023 | 0.61x | ₩5.44 Billion | ₩3.29 Billion | ▼ -84.7% |
| 2021 | 3.95x | ₩7.78 Billion | ₩30.75 Billion | ▲ +143.6% |
| 2020 | 1.62x | ₩2.68 Billion | ₩4.34 Billion | ▼ -33.6% |
| 2019 | 2.44x | ₩2.52 Billion | ₩6.16 Billion | ▲ +1053.3% |
| 2018 | 0.21x | ₩4.22 Billion | ₩892.34 Million | ▼ -74.7% |
| 2017 | 0.84x | ₩1.84 Billion | ₩1.54 Billion | ▲ +88.9% |
| 2016 | 0.44x | ₩7.75 Billion | ₩3.43 Billion | ▲ +107.8% |
| 2015 | 0.21x | ₩3.62 Billion | ₩771.87 Million | ▼ -4.0% |
| 2011 | 0.22x | ₩2.89 Billion | ₩642.43 Million | — |